Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 37 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT04836507
- Conditions
- ALL (Acute B-Lymphoblastic Leukemia), Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, +15 more
- Locations
-
- Samsung Medical Center Seoul, South Korea
- The Catholic University of Korea Seoul St. Mary's Hospital Seoul, South Korea
NCT06458439
- Conditions
- Hemic and Lymphatic Diseases, High-grade B-cell Lymphoma, Immune System Diseases, +12 more
- Locations
-
- Abramson Cancer Center at the University of Pennsylvania Philadelphia, Pennsylvania, United States
Recruiting
SynKIR-310 for Relapsed/Refractory B-NHL
NCT06544265
- Conditions
- Aggressive B-Cell Non-Hodgkin Lymphoma, B Cell Lymphoma, Blood Protein Disorders, +54 more
- Locations
-
- Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute Denver, Colorado, United States
- Winship Cancer Institute of Emory University Atlanta, Georgia, United States
- The University of Kansas Cancer Center Fairway, Kansas, United States
- Rutgers Cancer Institute New Brunswick, New Jersey, United States
Recruiting
Study of CAR-T Therapy in Older Patients
NCT04300998
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, DLBCL NOS, +19 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
NCT06208735
- Conditions
- B-cell Acute Lymphoblastic Leukemia, B-cell Leukemia, B-cell Lymphoma, +28 more
- Locations
-
- Arthur J.E. Child Comprehensive Cancer Centre Calgary, Alberta, Canada
- Alberta Children's Hospital Calgary, Alberta, Canada
- Vancouver General Hospital Vancouver, British Columbia, Canada
- BC Children's Hospital Vancouver, British Columbia, Canada
NCT06533579
- Conditions
- B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Chronic Disease, +40 more
- Locations
-
- City of Hope Duarte, California, United States
- Valkyrie Clinical Trials Los Angeles, California, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
- New York Medical College Valhalla, New York, United States
Recruiting
CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma
NCT06026319
- Conditions
- Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Grade 3b Follicular Lymphoma, +21 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT05256641
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, High-grade B-cell Lymphoma, +12 more
- Locations
-
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- University of Oklahoma Oklahoma City, Oklahoma, United States
Recruiting
Study of SGR-1505 in Mature B-Cell Neoplasms
NCT05544019
- Conditions
- ALK-Positive Large B-Cell Lymphoma, Blood Protein Disorders, Burkitt Lymphoma, +66 more
- Locations
-
- Banner Health - MD Anderson Cancer Center Gilbert, Arizona, United States
- Christiana Care Hospital - Helen F Graham Cancer Center Newark, Delaware, United States
- Napa Research Pompano Beach, Florida, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
NCT06693830
- Conditions
- Diffuse Large B Cell Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Hemic and Lymphatic Diseases, +15 more
- Locations
-
- Columbia University New York, United States
NCT06588205
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, +11 more
- Locations
-
- A.O.U. SS. Antonio e Biagio e C. Arrigo - S.C.D.U. Ematologia Alessandria, Italy
- A.O.U. Ospedali Riuniti delle Marche - Clinica di Ematologia Ancona, Italy
- I.R.C.C.S. Istituto Tumori Giovanni Paolo II - U.O.C. Ematologia Bari, Italy
- ASST Spedali Civili - S.C. Ematologia Brescia, Italy
NCT06736613
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Diffuse Large B Cell Lymphoma, +21 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
NCT06550141
- Conditions
- Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +16 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Recruiting
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
NCT06343311
- Conditions
- B-Cell Non-Hodgkin's Lymphoma (NHL), CNS Lymphoma, HIV Associated Lymphoma, +21 more
- Locations
-
- University of California, Davis Sacramento, California, United States
- Baylor Scott & White Research Institute, Texas Oncology Dallas, Texas, United States
NCT06287398
- Conditions
- DLBCL - Diffuse Large B Cell Lymphoma, DLBCL, Nos Genetic Subtypes, Dendritic Cell Sarcoma, Interdigitating, +21 more
- Locations
-
- Australasian Leukemia and Lymphoma Group Melbourne, Victoria, Australia
Not Yet Recruiting
Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)
NCT07225439
- Conditions
- B-cell Non Hodgkin Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +30 more
- Locations
-
- Case Comprehensive Cancer Center, University Hospitals Seidman Cancer Center Cleveland, Ohio, United States
- Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute Cleveland, Ohio, United States
Not Yet Recruiting
TPG: Tafasitamab, Polatuzumab Vedotin, and Glofitamab as First-line Therapy for Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma
NCT07502872
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, High-grade B-cell Lymphoma, +10 more
- Locations
-
- Rhode Island Hospital Providence, Rhode Island, United States
Not Yet Recruiting
Omic Technologies Applied to the Study of B-cell Lymphoma for the Discovery of Diagnostic and Prognosis Biomarkers
NCT05834426
- Conditions
- Cancer, Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- Instituto Oncológico Nacional Dr. Juan Tanca Marengo Guayaquil, Guayas, Ecuador
NCT05653271
- Conditions
- B-cell Lymphoma, Burkitt Lymphoma, DLBCL, +23 more
- Locations
-
- AdventHealth Orlando Orlando, Florida, United States
- Emory University Atlanta, Georgia, United States
- Indiana University Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
- Norton Cancer Institute Louisville, Kentucky, United States
NCT04067414
- Conditions
- Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, High-grade B-cell Lymphoma, +12 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital Tianjin, China